Geusens P, Oates M, Miyauchi A, et al. Romosozumab rapidly reduces clinical vertebral fracture incidence: results from the FRAME study. EULAR 2017, OP0048.
Anti-C5a-antilichaam vilobelimab veilig bij ernstige COVID-19
feb 2021 | Pneumonie, Virale infecties